相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Meta-analysis of macrolide maintenance therapy for prevention of disease exacerbations in patients with noncystic fibrosis bronchiectasis
Donghai Wang et al.
MEDICINE (2019)
Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections A Road Map for Research
Shelby Daniel-Wayman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii
Zofia Bakula et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease
Byung Woo Jhun et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Microbiologic Outcome of Interventions Against Mycobacterium avium Complex Pulmonary Disease A Systematic Review
Roland Diel et al.
CHEST (2018)
How to: identify non-tuberculous Mycobacterium species using MALDI-TOF mass spectrometry
F. Alcaide et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement
Jakko van Ingen et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT)
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
A definition of the Mycobacterium avium complex for taxonomical and clinical purposes, a review
Jakko van Ingen et al.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2018)
Clinical Characteristics and Treatment Outcomes of Patients with Macrolide-Resistant Mycobacterium massiliense Lung Disease
Hayoung Choi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies
Faiza Mougari et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
Jimyung Park et al.
CLINICAL INFECTIOUS DISEASES (2017)
Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease
Won-Jung Koh et al.
CLINICAL INFECTIOUS DISEASES (2017)
Natural history of Mycobacterium avium complex lung disease in untreated patients with stable course
Ji An Hwang et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype
Won-Jung Koh et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Meta-analyses and the evidence base for microbial outcomes in the treatment of pulmonary Mycobacterium avium-intracellulare complex disease
Jotam G. Pasipanodya et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Comparison of Saramis 4.12 and IVD 3.0 Vitek MS Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Mycobacteria from Solid and Liquid Culture Media
Caroline Leyer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2017)
The clinical efficacy of a clarithromycin-based regimen for Mycobacterium avium complex disease: A nationwide post-marketing study
Jun-ichi Kadota et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2017)
Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohort
Sanne Zweijpfenning et al.
RESPIRATORY MEDICINE (2017)
Systematic Review and Meta-analyses of the Effect of Chemotherapy on Pulmonary Mycobacterium abscessus Outcomes and Disease Recurrence
Jotam G. Pasipanodya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Treatment Outcomes of Mycobacterium avium Complex Lung Disease: A Systematic Review and Meta-analysis
Nakwon Kwak et al.
CLINICAL INFECTIOUS DISEASES (2017)
The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases
Kazuma Yagi et al.
BMC INFECTIOUS DISEASES (2017)
Microbiological and Clinical Outcomes of Treating Non Mycobacterium Avium Complex Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Review and Meta-Analysis
Roland Diel et al.
CHEST (2017)
Adult Patients With Bronchiectasis A First Look at the US Bronchiectasis Research Registry
Timothy R. Aksamit et al.
CHEST (2017)
Randomized Trial of Liposomal Amikacin for Inhlation in Nontuberculous Mycobacterial Lung Disease
Kenneth N. Olivier et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Pulmonary Nontuberculous Mycobacteria-Associated Deaths, Ontario, Canada, 2001-2013
Theodore K. Marras et al.
EMERGING INFECTIOUS DISEASES (2017)
Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin
Beatriz E. Ferro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Safety of IV amikacin in the treatment of pulmonary non-tuberculous mycobacterial disease
Claire M. Ellender et al.
RESPIROLOGY (2016)
Peak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung Disease
Byeong-Ho Jeong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung Disease
Seong Mi Moon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series
Ho Namkoong et al.
BMC INFECTIOUS DISEASES (2016)
Oral Macrolide Therapy Following Short-term Combination Antibiotic Treatment of Mycobacterium massiliense Lung Disease
Won-Jung Koh et al.
CHEST (2016)
Long-term Follow-up of Mycobacterium avium Complex Lung Disease in Patients Treated With Regimens Including Clofazimine and/or Rifampin
Julie Jarand et al.
CHEST (2016)
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
Payam Nahid et al.
CLINICAL INFECTIOUS DISEASES (2016)
Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp abscessus and Mycobacterium abscessus subsp bolletii and designation of Mycobacterium abscessus subsp massiliense comb. nov.
Enrico Tortoli et al.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2016)
Microbiological criteria in non-tuberculous mycobacteria pulmonary disease: a tool for diagnosis and epidemiology
M. Jankovic et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2016)
Standardized interpretation of antibiotic susceptibility testing and resistance genotyping for Mycobacterium abscessus with regard to subspecies and erm41 sequevar
Faiza Mougari et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Fails To Identify Nontuberculous Mycobacteria from Primary Cultures of Respiratory Samples
Kim van Eck et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2016)
Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study
Timothy M. Rawson et al.
RESPIRATORY MEDICINE (2016)
Diagnostic Molecular Mycobacteriology in Regions With Low Tuberculosis Endemicity: Combining Real-time PCR Assays for Detection of Multiple Mycobacterial Pathogens With Line Probe Assays for Identification of Resistance Mutations
Vanessa Deggim-Messmer et al.
EBIOMEDICINE (2016)
Improvement in Quality of Life after Therapy for Mycobacterium abscessus Group Lung Infection A Prospective Cohort Study
Christopher A. Czaja et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2016)
Treatment of Mycobacterium abscessus Infection
Shannon A. Novosad et al.
EMERGING INFECTIOUS DISEASES (2016)
Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases
Kozo Morimoto et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2016)
Patient-Centered Research Priorities for Pulmonary Nontuberculous Mycobacteria (NTM) Infection An NTM Research Consortium Workshop Report
Emily Henkle et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2016)
Semiquantitative Culture Analysis during Therapy for Mycobacterium avium Complex Lung Disease
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Intermittent Antibiotic Therapy for Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease
Byeong-Ho Jeong et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease
Won-Jung Koh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Rapid Drug Tolerance and Dramatic Sterilizing Effect of Moxifloxacin Monotherapy in a Novel Hollow-Fiber Model of Intracellular Mycobacterium kansasii Disease
Shashikant Srivastava et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Treatment outcomes of adjuvant resectional surgery for nontuberculous mycobacterial lung disease
Hyung Koo Kang et al.
BMC INFECTIOUS DISEASES (2015)
The Significance of Mycobacterium abscessus Subspecies abscessus Isolation During Mycobacterium avium Complex Lung Disease Therapy
David E. Griffith et al.
CHEST (2015)
Factors associated with subsequent nontuberculous mycobacterial lung disease in patients with a single sputum isolate on initial examination
M. -R. Lee et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Treatment of Slowly Growing Mycobacteria
Julie V. Philley et al.
CLINICS IN CHEST MEDICINE (2015)
Epidemiology of Human Pulmonary Infection with Nontuberculous Mycobacteria A Review
D. Rebecca Prevots et al.
CLINICS IN CHEST MEDICINE (2015)
Time-kill kinetics of slowly growing mycobacteria common in pulmonary disease
Beatriz E. Ferro et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients
Anne-Laure Roux et al.
JOURNAL OF CYSTIC FIBROSIS (2015)
Risk factors for microbiologic failure among Taiwanese adults with Mycobacterium abscessus complex pulmonary disease
Yu-Jung Tung et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2015)
Risk factors for mortality in patients with pulmonary infections with non-tuberculous mycobacteria: A retrospective cohort study
E. P. A. T. Gommans et al.
RESPIRATORY MEDICINE (2015)
Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium complex lung disease
Mina Gochi et al.
BMJ OPEN (2015)
Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012
Emily Henkle et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2015)
Comparison of MALDI-TOF MS With HPLC and Nucleic Acid Sequencing for the Identification of Mycobacterium Species in Cultures Using Solid Medium and Broth
Blake W. Buchan et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
Comparison of the Spectrum of Radio logic and Clinical Manifestations of Pulmonary Disease Caused by Mycobacterium avium Complex and Mycobacterium xenopi
Maria C. Carrillo et al.
CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES (2014)
Macrolide/Azalide Therapy for Nodular/Bronchiectatic Mycobacterium avium Complex Lung Disease
Richard J. Wallace et al.
CHEST (2014)
Utility of rpoB Gene Sequencing for Identification of Nontuberculous Mycobacteria in the Netherlands
Rina de Zwaan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease
Jiwon Lyu et al.
RESPIRATORY MEDICINE (2014)
Mycobacterium avium complex infection in non-cystic fibrosis bronchiectasis
Zaid Zoumot et al.
RESPIROLOGY (2014)
Factors associated with quality of life measured by EQ-5D in patients with nontuberculous mycobacterial pulmonary disease
Ji Young Hong et al.
QUALITY OF LIFE RESEARCH (2014)
Clinical significance of a single isolation of pathogenic nontuberculous mycobacteria from sputum specimens
Won-Jung Koh et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2013)
Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significance
Jakko van Ingen et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Pharmacokinetic studies in patients with nontuberculous mycobacterial lung infections
C. Magis-Escurra et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Drug susceptibility distributions in slowly growing non-tuberculous mycobacteria using MGIT 960 TB eXiST
Michael Hombach et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2013)
Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapy
Claire Andrejak et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength
Jeffrey C. Andrews et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
In Vitro Activity of Amikacin against Isolates of Mycobacterium avium Complex with Proposed MIC Breakpoints and Finding of a 16S rRNA Gene Mutation in Treated Isolates
Barbara A. Brown-Elliott et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies
Stuart Schembri et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Pulmonary Nontuberculous Mycobacterial Disease, Ontario, Canada, 1998-2010
Theodore K. Marras et al.
EMERGING INFECTIOUS DISEASES (2013)
Macrolide Treatment for Mycobacterium abscessus and Mycobacterium massillense Infection and Inducible Resistance
Go-Eun Choi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Prognostic Factors of 634 HIV-Negative Patients with Mycobacterium avium Complex Lung Disease
Makoto Hayashi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Prevalence of Nontuberculous Mycobacterial Lung Disease in US Medicare Beneficiaries
Jennifer Adjemian et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
The Pharmacokinetics and Pharmacodynamics of Pulmonary Mycobacterium avium Complex Disease Treatment
Jakko van Ingen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Therapeutic Drug Monitoring in the Treatment of Mycobacterium avium Complex Lung Disease
Won-Jung Koh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
In Vitro Synergy between Clofazimine and Amikacin in Treatment of Nontuberculous Mycobacterial Disease
Jakko van Ingen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria
Barbara A. Brown-Elliott et al.
CLINICAL MICROBIOLOGY REVIEWS (2012)
Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria
Jakko van Ingen et al.
DRUG RESISTANCE UPDATES (2012)
Aerosolized amikacin in patients with difficult-to-treat pulmonary nontuberculous mycobacteriosis
A. Safdar
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
Are phylogenetic position, virulence, drug susceptibility and in vivo response to treatment in mycobacteria interrelated?
Jakko van Ingen et al.
INFECTION GENETICS AND EVOLUTION (2012)
Long-term radiographic outcome of nodular bronchiectatic Mycobacterium avium complex pulmonary disease
S. Kitada et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
Predictors of 5-year mortality in pulmonary Mycobacterium avium-intracellulare complex disease
Y. Ito et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
Acquisition of clarithromycin resistance mutations in the 23S rRNA gene of Mycobacterium abscessus in the presence of inducible erm(41)
Florian P. Maurer et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Clinical and Microbiological Differences between Mycobacterium abscessus and Mycobacterium massiliense Lung Diseases
Toshiyuki Harada et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease
Masaki Fujita et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2012)
Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period
Yoshihiro Kobashi et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2012)
Characterization of a novel variant of Mycobacterium chimaera
J. van Ingen et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2012)
Clinical Significance of Differentiation of Mycobacterium massiliense from Mycobacterium abscessus
Won-Jung Koh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Assessment of Clarithromycin Susceptibility in Strains Belonging to the Mycobacterium abscessus Group by erm(41) and rrl Sequencing
Sylvaine Bastian et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
Julie Jarand et al.
CLINICAL INFECTIOUS DISEASES (2011)
Lady Windermere revisited: treatment with thoracoscopic lobectomy/segmentectomy for right middle lobe and lingular bronchiectasis associated with non-tuberculous mycobacterial disease
Jessica A. Yu et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2011)
GRADE guidelines: 2. Framing the question and deciding on important outcomes
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables
Gordon Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Multilocus Sequence Analysis and rpoB Sequencing of Mycobacterium abscessus (Sensu Lato) Strains
Edouard Macheras et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Evaluation of BacT/Alert 3D Automated Unit for Detection of Nontuberculous Mycobacteria Requiring Incubation at 30°C for Optimal Growth
Michelle J. Alfa et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Clinical Characteristics and Prognosis of Nontuberculous Mycobacterial Lung Disease with Different Radiographic Patterns
Chin-Chung Shu et al.
LUNG (2011)
Impaired health-related quality of life in pulmonary nontuberculous mycobacterial disease
Mauli Mehta et al.
RESPIRATORY MEDICINE (2011)
Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs
Jiwon Lyu et al.
RESPIRATORY MEDICINE (2011)
Nontuberculous Mycobacterial Lung Disease Prevalence at Four Integrated Health Care Delivery Systems
D. Rebecca Prevots et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Nontuberculous Pulmonary Mycobacteriosis in Denmark Incidence and Prognostic Factors
Claire Andrejak et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Re-analysis of 178 previously unidentifiable Mycobacterium isolates in the Netherlands in 1999-2007
J. van Ingen et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Commercial DNA Probes for Mycobacteria Incorrectly Identify a Number of Less Frequently Encountered Species
Enrico Tortoli et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Detection and Identification of Mycobacterium spp. in Clinical Specimens by Combining the Roche Cobas Amplicor Mycobacterium tuberculosis Assay with Mycobacterium Genus Detection and Nucleic Acid Sequencing
S. Peter-Getzlaff et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Clinical Outcome of Mycobacterium abscessus Infection and Antimicrobial Susceptibility Testing
Yi-Ching Huang et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2010)
Antibiotic Treatment of Mycobacterium abscessus Lung Disease A Retrospective Analysis of 65 Patients
Kyeongman Jeon et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae
Kevin A. Nash et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease
M. Santin et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Tuberculosis pharmacotherapy: strategies to optimize patient care
Carole D. Mitnick et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Cohort Study of Molecular Identification and Typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii
Adrian M. Zelazny et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Mycobacterium xenopi pulmonary disease - Epidemiology and clinical features in non-immunocompromised patients
Ante Marusic et al.
JOURNAL OF INFECTION (2009)
Clinical relevance of Mycobacterium chelonae-abscessus group isolation in 95 patients
Jakko van Ingen et al.
JOURNAL OF INFECTION (2009)
Comparative Evaluation of Three Culture Methods for the Isolation of Mycobacteria from Clinical Samples
Antonio Sorlozano
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2009)
Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France
C. Andrejak et al.
THORAX (2009)
Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands
J. van Ingen et al.
THORAX (2009)
Anatomic lung resection for nontuberculous mycobacterial disease
John D. Mitchell et al.
ANNALS OF THORACIC SURGERY (2008)
Clarithromycin for 2 weeks for stable coronary heart disease: 6-year follow-up of the CLARICOR randomized trial and updated meta-analysis of antibiotics for coronary heart disease
Christian Gluud et al.
CARDIOLOGY (2008)
Surgical treatment of pulmonary diseases due to nontuberculous mycobacteria
Won-Jung Koh et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2008)
Concomitant use of voriconazole and rifabutin in a patient with multiple infections
Joshua N. Schwiesow et al.
PHARMACOTHERAPY (2008)
Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy
P. A. Jenkins et al.
THORAX (2008)
Mycobacterium xenopi clinical relevance and determinants, the Netherlands
Jakko van Ingen et al.
EMERGING INFECTIOUS DISEASES (2008)
Non-tuberculous mycobacteria pulmonary infection:: Management and follow-up of 31 infected patients
Claire Andrejak et al.
JOURNAL OF INFECTION (2007)
An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease
Yoshihiro Kobashi et al.
RESPIRATORY MEDICINE (2007)
Use of the BACTEC mycobacteria growth indicator tube 960 automated system for recovery of mycobacteria from 9,558 extrapulmonary specimens, including urine samples
Doris Hillemann et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
An official ATS statement:: Grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations
Holger J. Schuenemann et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease
Phung K. Lam et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones
Masazumi Watanabe et al.
ANNALS OF THORACIC SURGERY (2006)
Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004 -: Clinical features, drug susceptibility, and outcome
D Shitrit et al.
CHEST (2006)
Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease
DE Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
In vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii
R Guna et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria
M Cruciani et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Pneumonectomy for nontuberculous mycobacterial infections
Y Shiraishi et al.
ANNALS OF THORACIC SURGERY (2004)
Mycobacterium avium complex pulmonary disease in patients without HIV infection
SK Field et al.
CHEST (2004)
Assessment of partial sequencing of the 65-kilodalton heat shock protein gene (hsp65) for routine identification of Mycobacterium species isolated from clinical sources
A McNabb et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Comparative in vitro activities of linezolid, telithromycin, clarithromycin, levofloxacin, moxifloxacin, and four conventional antimycobacterial drugs against Mycobacterium kansasii
F Alcaide et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Aminoglycoside toxicity: Daily versus thrice-weekly dosing for treatment of mycobacterial diseases
CA Peloquin et al.
CLINICAL INFECTIOUS DISEASES (2004)
rpoB-based identification of nonpigmented and late-pigmenting rapidly growing mycobacteria
T Adékambi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome
CA Benson et al.
CLINICAL INFECTIOUS DISEASES (2003)
Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine
SK Field et al.
CHEST (2003)
Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients:: five year follow-up of patients receiving standardised treatment
PA Jenkins et al.
RESPIRATORY MEDICINE (2003)
Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: Results of a preliminary study
DE Griffith et al.
CLINICAL INFECTIOUS DISEASES (2003)
Surgery for Mycobacterium avium complex lung disease in the clarithromycin era
Y Shiraishi et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2002)
Pulmonary resection for Mycobacterium xenopi pulmonary infection
L Lang-Lazdunski et al.
ANNALS OF THORACIC SURGERY (2001)
Efficacies of clarithromycin regimens against Mycobacterium xenopi in mice
N Lounis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease
DE Griffith et al.
CLINICAL INFECTIOUS DISEASES (2001)
Comparison of the automated nonradiometric Bactec MGIT 960 system with Lowenstein-Jensen, Coletsos, and Middlebrook 7H11 solid media for recovery of mycobacteria
P Idigoras et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2000)
Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex
DE Griffith et al.
CLINICAL INFECTIOUS DISEASES (2000)
分享论文
